Diabetes Treatment Drugs Market Drug Class Analysis
Drug class segmentation defines the Diabetes Treatment Drugs Market structure. Insulin remains the cornerstone therapy, projected to grow from $30 billion in 2024 to $37 billion by 2035. It is essential for Type 1 diabetes management and increasingly utilized in advanced Type 2 cases.
Sulfonylureas maintain steady demand as effective oral hypoglycemic agents for Type 2 diabetes. DPP-4...
0 Condivisioni
22 Visualizzazioni